TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Total Debt Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual total debt in 2023 was 131.77 Million TWD , up 152.48% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly total debt in 2023 FY was 131.77 Million TWD , up 152.48% from previous quarter.
  • TFBS Bioscience Inc. reported annual total debt of 52.19 Million TWD in 2022, up 144.44% from previous year.
  • TFBS Bioscience Inc. reported annual total debt of 21.35 Million TWD in 2021, up 8.55% from previous year.
  • TFBS Bioscience Inc. reported quarterly total debt of 131.77 Million TWD for 2023 Q4, up 249.34% from previous quarter.
  • TFBS Bioscience Inc. reported quarterly total debt of 37.72 Million TWD for 2023 Q2, down -27.73% from previous quarter.

Annual Total Debt Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual Total Debt of TFBS Bioscience Inc. (2023 - 2020)

Year Total Debt Total Debt Growth
2023 131.77 Million TWD 152.48%
2022 52.19 Million TWD 144.44%
2021 21.35 Million TWD 8.55%
2020 19.67 Million TWD 0.0%

Peer Total Debt Comparison of TFBS Bioscience Inc.

Name Total Debt Total Debt Difference
BIONET Corp. 45.01 Million TWD -192.736%
DIVA Laboratories, Ltd. 2.53 Million TWD -5104.265%
Genetics Generation Advancement Corp. 49.29 Million TWD -167.302%
Welgene Biotech Co.,Ltd. 154.34 Million TWD 14.626%
Puriblood Medical Co., Ltd. 51.64 Million TWD -155.169%